Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big pharma M&A moves in the red-hot radiopharmaceuticals space.